Get started Log in

HEMO — Hemogenyx Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

CBR Patent Application Update
08/09/2023 17:11
UK's Hemogenyx Pharma gains as co takes action to tackle USFDA concerns
10/07/2023 09:41
Brief: Hemogenyx Pharma Gets USFDA Full Review Letter On INDA For Candidate Chimeric Antigen Receptor T-Cells
10/07/2023 07:32
Posting of Annual Report & Notice of AGM
02/06/2023 14:01
UK's Hemogenyx falls on FDA clinical hold for leukemia cancer drug
02/06/2023 13:02
Brief: Hemogenyx Pharma Says Clinical Hold On IND For Hemo-Car-T
02/06/2023 11:31
Brief: Hemogenyx Pharmaceuticals Announces Submission Of IND For Hemo-Car-T
09/05/2023 07:56
Equity Incentive Pool Increase and Option Grant
28/04/2023 10:05
Final Results for the Year Ended 31 December 2022
28/04/2023 07:00
Hemo: CAR-T Analytical Release Tests Completed
23/03/2023 13:32
Admission of Shares to Official List
07/02/2023 14:30
Second Price Monitoring Extn
26/01/2023 09:05
Price Monitoring Extension
26/01/2023 09:00
Brief: Hemogenyx Pharma Announces Placing To Raise £4.1 Mln
26/01/2023 08:40
Placing to Raise £4,056,250
26/01/2023 07:00
Brief: Hemogenyx Pharmaceuticals Announces Completion Of Third Process Qualification Run For Manufacture Of Hemo-Car-T Cells
23/01/2023 07:43
Hemo: CAR-T 3rd Process Qualification Run Completed
23/01/2023 07:00
Second Price Monitoring Extn
16/01/2023 16:40
Price Monitoring Extension
16/01/2023 16:35
Second Price Monitoring Extn
13/01/2023 11:05